C-Reactive Protein as a Prognostic Marker After Lacunar Stroke: Levels of Inflammatory Markers in the Treatment of Stroke Study
暂无分享,去创建一个
Mark D. Johnson | David C. Anderson | P. Karanjia | Mahboob Rahman | H. Lutsep | C. Jacova | N. Buchheimer | L. Tenteromano | D. Naritoku | C. Benesch | C. Kase | J. Arenillas | J. Graves | B. Meyer | P. Gamble | G. Howard | J. Weinberger | R. Dart | R. Grimm | C. Coffey | J. Yee | D. Anderson | R. Cote | O. Benavente | A. Arauz | M. Gomis | A. Dávalos | A. Doherty | J. Romano | M. King | J. Bisognano | B. Demaerschalk | L. McClure | L. Pettigrew | Mitchell S. V. Elkind | R. Talbert | I. Gavras | A. Arboix | S. Cruz-Flores | C. Katholi | L. Lennihan | Saran Vaughn | T. Mirsen | I. Meissner | D. Lefkowitz | S. Bailey | Yu Zhang | O. D. Del Brutto | M. Zambrano | Steve Holliday | Marilou I Ching | B. Coull | C. Bazan | C. Jackson | M. Castellanos | Kalyani Peri | L. Carpenter | J. Luna | R. Crew | J. Kappler | I. Godoy | David Carpenter | N. Murali | K. Mancl | K. Khan | S. Brunet | J. Roquer | F. Gudiol | Jaime Rodríguez | J. Tapia | R. Atkinson | N. Allen | H. Goecke | B. Silver | E. Pretell | Antoni Pelegrí | D. Book | A. Fontaine | J. Warner | L. Pearce | D. Bruck | I. Jiménez | J. Szychowski | P. Zrelak | C. White | R. Van Stavern | R. Sawyer | Joaquín Serena Leal | Laurence Green | M. Cingel | S. Palacio | S. Sundararajan | L. Gaertner | A. Roldan | N. Kelly | R. Zweifler | D. Brauer | D. Simcox | D. Wochos | L. Wadup | E. Holzemer | J. Covalt | K. Wilson | T. Hamm | L. Berger | Melinda M. Parnell | R. Mailhot | S. Reverté | F. Borrego | Yu Zhang | Barbara Cleary | Creed L Pettigrew | R. Drinkard | A. Vaishnav | Patricia Niblack | A. Katramados | Helena W Lau | A. Bastien | Angela Brown | G. Ortiz | G. Romeral | I. Castro | R. Santibanez | L. Blanco | J. Zentner | L. Wright | S. Mcallister | J. Wieser | Ana Rodríguez | G. Pérgola | M. Rodríguez | M. Hogan | Anna-Kate Fowler | Tania Corporan | P. Pergola | W. Polashenski | Matthew Ogrodnik | W. Logan | J. Diaz | Lori Wood | Darren T Larsen | Gregg Wright | J. J. Conde | J. Hanna | D. Racicot | Julie D. Naylor | M. Jacoby | J. Pozo | J. Hollander | T. Zipp | Rachel Stone | C. Weber | Megan V. Ross | M. J. Sewell | K. Parkes | S. Eapen | Robert Goldsteen | A. Liskay | G. Matamala | Verónica Cruz | J. Lara | Cheryl Conover | Oscar R. Benavente | J. Greenberg | C. Kelly | Naomie Gathua | Peter Sawaya | N. Hughes | Johnya Rice | K. Vanderpool | Jo Bell | Deb Herzig | H. D. Walden | Lien Howard | Mina Malekniazi | Melissa VanSkiver | S. Redman | D. Cook | Krisy Aiello | Sharon McCarthy | Michael A. Culpepper | Robin Yunker | Kelly Boots | Rachel Backlin | Jai Radhakrishan | Rebeca Aragon | Oscar Benavente | Robert Hart | Arlene Farias | T. Horvath | David Korosec | C. Murphy | Don Girard | K. Seisler | Clarence Grimm | B. Blaney | S. Rozman | Erin Bradenburg | L. Loomis | Jolene Monarch-Cotton | Jean Ravavelli-Meyer | A. Golembieski | Maria del Carmen Lichtenberger | Yinghui Liu | April Blair | David Jones | Jeffrey DeFrancisco | S. Burgin | J. Hollander | Patricia M. Wallace | Lorainne Pereira | Dorothy Burch | Ann M Leonhardt | M. Hildreth | L. Pavel | E. Smith | J. Satterfield | Jannie S. Serna | J. Newgent | Ashfaq Shuab | Naeen Dean | F. Herbert | Karen Kastelic | R. Lieberman | T. Carter | Nola Kenney | S. Schroer | Johanne Pontbriand | Martine Mainville | M. Valdes | Marcela Parra | J. L. Ruiz Sandoval | E. S. Vasquez | C. Ruiz | G. Cervantes | Adolfo Leyva | I. Camacho | José Valdivia | Marissa Pretell | M. Cepeda | A. Sunol | A. Serrano | José Antonio Castillo Sánchez | Miguel Blanco González | Christopher Coffey | Charles Allcorn | L. Irby | F. Guyton | M. Benavente | Camilla Robu | Eduardo Martinez | Raymond Costello | Luisa Camelia | Crystal Mendoza | Brandy Pratt | Christopher S. Coffey | Creed L. Pettigrew | Cheryl Weber | R. Aragon | Susan Mcallister | Darren T. Larsen | C. Conover | Ivan Esteban Godoy | J. Ruiz Sandoval | G. Amin Cervantes | Ana Serrano | M. Sewell | Joffre Lara | C. Grimm | A. Suñol
[1] R. Conwit,et al. Blood-pressure targets in patients with recent lacunar stroke: the SPS3 randomised trial , 2013, The Lancet.
[2] Christopher S Coffey,et al. Sample size re-estimation in an on-going NIH-sponsored clinical trial: the secondary prevention of small subcortical strokes experience. , 2012, Contemporary clinical trials.
[3] C. Coffey,et al. Effects of clopidogrel added to aspirin in patients with recent lacunar stroke. , 2012, The New England journal of medicine.
[4] W. Rosamond,et al. Racial-Ethnic Disparities in Stroke Care: The American Experience A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association , 2011, Stroke.
[5] R. Conwit,et al. The Secondary Prevention of Small Subcortical Strokes (SPS3) Study , 2011, International journal of stroke : official journal of the International Stroke Society.
[6] M. Elkind,et al. The Levels of Inflammatory Markers in the Treatment of Stroke Study (Limits): Inflammatory Biomarkers as Risk Predictors after Lacunar Stroke , 2010, International journal of stroke : official journal of the International Stroke Society.
[7] J. Danesh,et al. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis , 2010, The Lancet.
[8] P. Ridker,et al. Rosuvastatin in the Prevention of Stroke Among Men and Women With Elevated Levels of C-Reactive Protein: Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) , 2010, Circulation.
[9] R. Sacco,et al. High-sensitivity C-reactive protein predicts mortality but not stroke , 2009, Neurology.
[10] R. Sacco,et al. High-Sensitivity C-Reactive Protein and Lipoprotein-Associated Phospholipase A2 Stability Before and After Stroke and Myocardial Infarction , 2009, Stroke.
[11] P. Libby,et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. , 2008, The New England journal of medicine.
[12] J. Kril,et al. Neuropathologic correlates of white matter hyperintensities , 2008, Neurology.
[13] R. Sacco,et al. High-sensitivity C-reactive protein, lipoprotein-associated phospholipase A2, and outcome after ischemic stroke. , 2006, Archives of internal medicine.
[14] S. Homma,et al. Seropositivity to Chlamydia pneumoniae Is Associated With Risk of First Ischemic Stroke , 2006, Stroke.
[15] M. Woodward,et al. Associations of Inflammatory and Hemostatic Variables With the Risk of Recurrent Stroke , 2005, Stroke.
[16] C. DeCarli,et al. Total Homocysteine Is Associated With White Matter Hyperintensity Volume: The Northern Manhattan Study , 2005, Stroke.
[17] D. Sander,et al. Evaluation of C-Reactive Protein Measurement for Assessing the Risk and Prognosis in Ischemic Stroke: A Statement for Health Care Professionals From the CRP Pooling Project Members , 2005, Stroke.
[18] D. Sander,et al. Evaluation of C-Reactive Protein Measurement for Assessing the Risk and Prognosis in Ischemic Stroke A Statement for Health Care Professionals From the CRP Pooling Special Report , 2005 .
[19] R. Sacco,et al. Leukocyte count predicts outcome after ischemic stroke: the Northern Manhattan Stroke Study. , 2004, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.
[20] À. Rovira,et al. C-Reactive Protein Predicts Further Ischemic Events in First-Ever Transient Ischemic Attack or Stroke Patients With Intracranial Large-Artery Occlusive Disease , 2003, Stroke.
[21] Sidney C. Smith,et al. MARKERS OF INFLAMMATION AND CARDIOVASCULAR DISEASE: APPLICATION TO CLINICAL AND PUBLIC HEALTH PRACTICE: A STATEMENT FOR HEALTHCARE PROFESSIONALS FROM THE CENTERS FOR DISEASE CONTROL AND PREVENTION AND THE AMERICAN HEART ASSOCIATION , 2003 .
[22] K. Yano,et al. C-Reactive Protein and the Future Risk of Thromboembolic Stroke in Healthy Men , 2003, Circulation.
[23] A. Hofman,et al. Silent brain infarcts and the risk of dementia and cognitive decline. , 2003, The New England journal of medicine.
[24] C. Heeschen,et al. Soluble CD40 ligand in acute coronary syndromes. , 2003, The New England journal of medicine.
[25] Gary L Myers,et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. , 2003, Circulation.
[26] C. Heeschen,et al. Soluble CD 40 Ligand in Acute Coronary Syndromes , 2003 .
[27] Á. Chamorro,et al. A -174G/C polymorphism of the interleukin-6 gene in patients with lacunar infarction , 2002, Neuroscience Letters.
[28] R. Sacco,et al. Carotid Intima-Media Thickness Is Associated With Allelic Variants of Stromelysin-1, Interleukin-6, and Hepatic Lipase Genes: The Northern Manhattan Prospective Cohort Study , 2002, Stroke.
[29] Á. Chamorro,et al. Inflammation-Mediated Damage in Progressing Lacunar Infarctions: A Potential Therapeutic Target , 2002, Stroke.
[30] C. Wolfe,et al. Incidence and case fatality rates of stroke subtypes in a multiethnic population: the South London Stroke Register , 2002, Journal of neurology, neurosurgery, and psychiatry.
[31] K. Furie,et al. A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke. , 2001, The New England journal of medicine.
[32] Natalia S. Rost,et al. Plasma Concentration of C-Reactive Protein and Risk of Ischemic Stroke and Transient Ischemic Attack: The Framingham Study , 2001, Stroke.
[33] R. Sacco,et al. Glycine antagonist in neuroprotection for patients with acute stroke: GAIN Americas: a randomized controlled trial. , 2001, JAMA.
[34] M. Di Napoli,et al. Prognostic Influence of Increased C-Reactive Protein and Fibrinogen Levels in Ischemic Stroke , 2001, Stroke.
[35] Azar,et al. A COMPARISON OF WARFARIN AND ASPIRIN FOR THE PREVENTION OF RECURRENT ISCHEMIC STROKE , 2001 .
[36] R. Westendorp,et al. C-reactive protein is a strong but nonspecific risk factor of fatal stroke in elderly persons. , 2001, Arteriosclerosis, thrombosis, and vascular biology.
[37] G. Murray,et al. Medical complications after stroke: a multicenter study. , 2000, Stroke.
[38] W M O'Fallon,et al. Ischemic stroke subtypes : a population-based study of functional outcome, survival, and recurrence. , 2000, Stroke.
[39] R. Westendorp,et al. C-Reactive Protein Is a Strong but Nonspecific Risk Factor of Fatal Stroke in Elderly Persons , 2000 .
[40] E. Ford,et al. Serum C-reactive protein and self-reported stroke: findings from the Third National Health and Nutrition Examination Survey. , 2000, Arteriosclerosis, thrombosis, and vascular biology.
[41] W. Hacke,et al. Fever and infection early after ischemic stroke , 1999, Journal of the Neurological Sciences.
[42] R. Havlik,et al. Characterization of risk factors for vascular dementia , 1999, Neurology.
[43] K. Lees,et al. C-reactive protein and outcome after ischemic stroke. , 1999, Stroke.
[44] R. Adams,et al. Medical and neurological complications of ischemic stroke: experience from the RANTTAS trial. RANTTAS Investigators. , 1998, Stroke.
[45] J. Slattery,et al. Nonhypertensive cerebral small-vessel disease. An autopsy study. , 1997, Stroke.
[46] H. Ellis. stroke , 1997, The Lancet.
[47] R. Sacco,et al. Testing the validity of the lacunar hypothesis , 1997, Neurology.
[48] P. Ridker,et al. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. , 1997, The New England journal of medicine.
[49] J. Ferro,et al. Long-term prognosis of first-ever lacunar strokes. A hospital-based study. , 1996, Stroke.
[50] C. Warlow,et al. Complications after acute stroke. , 1996, Stroke.
[51] R. Sacco,et al. Hypertension and diabetes mellitus as determinants of multiple lacunar infarcts. , 1995, Stroke.
[52] Daniel B Hier,et al. Clinical-computed tomographic correlations of lacunar infarction in the Stroke Data Bank. , 1991, Stroke.
[53] AChamorro,et al. Clinical-computed tomographic correlations of lacunar infarction in the Stroke Data Bank. , 1991 .
[54] J. Garcìa,et al. Clinical study of 227 patients with lacunar infarcts. , 1990, Stroke.
[55] M. Cowan,et al. American Heart Association. , 2018, P & T : a peer-reviewed journal for formulary management.
[56] J Bamford,et al. The natural history of lacunar infarction: the Oxfordshire Community Stroke Project. , 1987, Stroke.
[57] M. O. Dayhoff,et al. Data bank , 1981, Nature.